Literature DB >> 19301078

Lipoprotein lipase expression in livers of morbidly obese patients could be responsible for liver steatosis.

Eva Pardina1, Juan A Baena-Fustegueras, Rafael Llamas, Roberto Catalán, Rosa Galard, Albert Lecube, Jose M Fort, Miquel Llobera, Helena Allende, Víctor Vargas, Julia Peinado-Onsurbe.   

Abstract

BACKGROUND: Most patients with morbid obesity develop non-alcoholic fatty liver disease (NAFLD). The origins of lipid deposition in the liver and the effects of bariatric surgery in the obese with NAFLD are controversial.
METHODS: We analyzed lipids and lipoprotein lipase (LPL) in both plasma and liver biopsies performed before and 12-18 months after Roux-en-Y gastric bypass surgery in 26 patients.
RESULTS: In the livers of morbidly obese patients, the levels of LPL messenger RNA (mRNA) were higher (4.5-fold) before surgery than afterwards than control livers. In these patients, LPL activity was also significantly higher (91 +/- 7 mU/g) than in controls (51 +/- 3 mU/g, p = 0.0026) and correlated with the severity of the liver damage. All hepatic lipids were significantly increased in obese patients; however, after bariatric surgery, these lipids, with the exception of NEFA, tended to recover to normal levels.
CONCLUSIONS: The liver of obese patients presented higher LPL activity than controls, and unlike the controls, this enzyme could be synthesized in the liver because it also present LPL mRNA. The presence of the LPL activity could enable the liver to capture circulating triacylglycerides, thus favoring the typical steatosis observed in these patients.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19301078     DOI: 10.1007/s11695-009-9827-5

Source DB:  PubMed          Journal:  Obes Surg        ISSN: 0960-8923            Impact factor:   4.129


  39 in total

Review 1.  Steatohepatitis in obese individuals.

Authors:  Wael I Youssef; Arthur J McCullough
Journal:  Best Pract Res Clin Gastroenterol       Date:  2002-10       Impact factor: 3.043

Review 2.  Pathogenesis of steatohepatitis.

Authors:  C P Day
Journal:  Best Pract Res Clin Gastroenterol       Date:  2002-10       Impact factor: 3.043

3.  Characterization of the lipolytic activity of endothelial lipase.

Authors:  Mary G McCoy; Gwo-Shing Sun; Dawn Marchadier; Cyrille Maugeais; Jane M Glick; Daniel J Rader
Journal:  J Lipid Res       Date:  2002-06       Impact factor: 5.922

4.  Lipoprotein lipase and cholesterol transfer activities of lean and obese Zucker rats.

Authors:  J Peinado-Onsurbe; M Blay; J Julve; J A Fernández-López; X Remesar; M Alemany
Journal:  Horm Metab Res       Date:  2001-08       Impact factor: 2.936

Review 5.  Effects of weight loss surgeries on liver disease.

Authors:  George L Blackburn; Edward C Mun
Journal:  Semin Liver Dis       Date:  2004-11       Impact factor: 6.115

6.  Neonatal extinction of liver lipoprotein lipase expression.

Authors:  J Peinado-Onsurbe; B Staels; S Deeb; I Ramirez; M Llobera; J Auwerx
Journal:  Biochim Biophys Acta       Date:  1992-07-15

7.  Association of liver steatosis with lipid oversecretion and hypotriglyceridaemia in C57BL/6j mice fed trans-10,cis-12-linoleic acid.

Authors:  Pascal Degrace; Laurent Demizieux; Joseph Gresti; Jean-Michel Chardigny; Jean-Louis Sébédio; Pierre Clouet
Journal:  FEBS Lett       Date:  2003-07-10       Impact factor: 4.124

8.  Lipoprotein lipase enables triacylglycerol hydrolysis by perfused newborn rat liver.

Authors:  L Giménez-Llort; J Vilanova; N Skottova; G Bengtsson-Olivecrona; M Llobera; M Q Robert
Journal:  Am J Physiol       Date:  1991-10

9.  Clinical and histologic spectrum of nonalcoholic fatty liver disease associated with normal ALT values.

Authors:  Pouneh Mofrad; Melissa J Contos; Mahmadul Haque; Carol Sargeant; Robert A Fisher; Velimir A Luketic; Richard K Sterling; Mitchell L Shiffman; Richard T Stravitz; Arun J Sanyal
Journal:  Hepatology       Date:  2003-06       Impact factor: 17.425

10.  Isoproterenol increases active lipoprotein lipase in adipocyte medium and in rat plasma.

Authors:  Xavier Ballart; Mariona Siches; Julia Peinado-Onsurbe; Dolores López-Tejero; Miquel Llobera; Ignasi Ramírez; Monique Q Robert
Journal:  Biochimie       Date:  2003-10       Impact factor: 4.079

View more
  20 in total

1.  Nuclear factor (erythroid-derived 2)-like 2 activation-induced hepatic very-low-density lipoprotein receptor overexpression in response to oxidative stress contributes to alcoholic liver disease in mice.

Authors:  Zhigang Wang; Xiaobing Dou; Songtao Li; Ximei Zhang; Xinguo Sun; Zhanxiang Zhou; Zhenyuan Song
Journal:  Hepatology       Date:  2014-02-25       Impact factor: 17.425

2.  Modulation of lipid metabolism in glycyrrhizic acid-treated rats fed on a high-calorie diet and exposed to short or long-term stress.

Authors:  Hui Ping Yaw; So Ha Ton; Hsien-Fei Chin; Muhammad Kaiser Abdul Karim; Hamish Alexander Fernando; Khalid Abdul Kadir
Journal:  Int J Physiol Pathophysiol Pharmacol       Date:  2015-03-20

3.  A screen in mice uncovers repression of lipoprotein lipase by microRNA-29a as a mechanism for lipid distribution away from the liver.

Authors:  Aras N Mattis; Guisheng Song; Kelly Hitchner; Roy Y Kim; Andrew Y Lee; Amar D Sharma; Yann Malato; Michael T McManus; Christine C Esau; Erich Koller; Suneil Koliwad; Lee P Lim; Jacquelyn J Maher; Robert L Raffai; Holger Willenbring
Journal:  Hepatology       Date:  2014-11-24       Impact factor: 17.425

4.  Hepatic CD36 downregulation parallels steatosis improvement in morbidly obese undergoing bariatric surgery.

Authors:  E Pardina; R Ferrer; J Rossell; D Ricart-Jané; K A Méndez-Lara; J A Baena-Fustegueras; A Lecube; J Julve; J Peinado-Onsurbe
Journal:  Int J Obes (Lond)       Date:  2017-05-10       Impact factor: 5.095

5.  Betaine Promotes Fat Accumulation and Reduces Injury in Landes Goose Hepatocytes by Regulating Multiple Lipid Metabolism Pathways.

Authors:  Jiying Liu; Ruilong Song; Shengyan Su; Nannan Qi; Qifa Li; Zhuang Xie; Shali Yu
Journal:  Animals (Basel)       Date:  2022-06-13       Impact factor: 3.231

Review 6.  Mechanisms of intrahepatic triglyceride accumulation.

Authors:  Claudia Ress; Susanne Kaser
Journal:  World J Gastroenterol       Date:  2016-01-28       Impact factor: 5.742

7.  Evidence of endoplasmic reticulum stress and liver inflammation in the American mink Neovison vison with benign hepatic steatosis.

Authors:  Kirsti Rouvinen-Watt; Catherine Pal; Timothy Martin; Lora Harris; Tessema Astatkie; Darya Kryzskaya; Vesa Kärjä; Anne-Mari Mustonen; Raija Tammi; Markku Tammi; Petteri Nieminen
Journal:  J Comp Physiol B       Date:  2014-07-31       Impact factor: 2.200

8.  Central melanin-concentrating hormone influences liver and adipose metabolism via specific hypothalamic nuclei and efferent autonomic/JNK1 pathways.

Authors:  Monica Imbernon; Daniel Beiroa; María J Vázquez; Donald A Morgan; Christelle Veyrat-Durebex; Begoña Porteiro; Adenis Díaz-Arteaga; Ana Senra; Silvia Busquets; Douglas A Velásquez; Omar Al-Massadi; Luis Varela; Marina Gándara; Francisco-Javier López-Soriano; Rosalía Gallego; Luisa M Seoane; Josep M Argiles; Miguel López; Roger J Davis; Guadalupe Sabio; Françoise Rohner-Jeanrenaud; Kamal Rahmouni; Carlos Dieguez; Ruben Nogueiras
Journal:  Gastroenterology       Date:  2012-11-06       Impact factor: 22.682

9.  Dietary walnut oil modulates liver steatosis in the obese Zucker rat.

Authors:  Anja Fink; Corinna E Rüfer; Julie Le Grandois; Alexander Roth; Dalal Aoude-Werner; Eric Marchioni; Achim Bub; Stephan W Barth
Journal:  Eur J Nutr       Date:  2013-08-13       Impact factor: 5.614

10.  Response of the hepatic transcriptome to aflatoxin B1 in domestic turkey (Meleagris gallopavo).

Authors:  Melissa S Monson; Robert E Settlage; Kevin W McMahon; Kristelle M Mendoza; Sumit Rawal; Hani S El-Nezami; Roger A Coulombe; Kent M Reed
Journal:  PLoS One       Date:  2014-06-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.